Huakang Biomedical Holdings Company Limited (HKG:8622)
Hong Kong · Delayed Price · Currency is HKD 0.3600
+0.0200 (5.88%)
Jul 18, 2025, 3:08 PM HKT
HKG:8622 Market Cap
HKG:8622 has a market cap or net worth of 170.16 million as of July 17, 2025. Its market cap has increased by 246.94% in one year.
Market Cap
170.16M
Enterprise Value
135.67M
Revenue
26.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
Market Cap Chart
Since December 13, 2018, HKG:8622's market cap has decreased from 188.00M to 170.16M, a decrease of -9.49%. That is a compound annual growth rate of -1.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 250.78B |
| Hansoh Pharmaceutical Group Company | 198.59B |
| Innovent Biologics | 146.84B |
| JD Health International | 145.13B |
| Sino Biopharmaceutical | 113.93B |
| WuXi Biologics | 111.09B |
| Akeso | 108.34B |
| CSPC Pharmaceutical Group | 98.18B |